Authors:
Ascioglu, S
Rex, JH
de Pauw, B
Bennett, JE
Bille, J
Crokaert, F
Denning, DW
Donnelly, JP
Edwards, JE
Erjavec, Z
Fiere, D
Lortholary, O
Maertens, J
Meis, JF
Patterson, TF
Ritter, J
Selleslag, D
Shah, PM
Stevens, DA
Walsh, TJ
Citation: S. Ascioglu et al., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An internationalconsensus, CLIN INF D, 34(1), 2002, pp. 7-14
Authors:
Ascioglu, S
De Pauw, BE
Donnelly, JP
Collette, L
Citation: S. Ascioglu et al., Reliability of clinical research on invasive fungal infections: a systematic review of the literature, MED MYCOL, 39(1), 2001, pp. 35-40
Citation: O. Uzon et al., Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. (vol 32, pg 1713, 2001), CLIN INF D, 33(5), 2001, pp. 749-749
Citation: O. Uzun et al., Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia, CLIN INF D, 32(12), 2001, pp. 1713-1717
Authors:
Cetinkaya, Y
Akova, M
Akalin, HE
Ascioglu, S
Hayran, M
Uzuns, O
Aksoyek, S
Tokgozoglu, L
Oto, A
Kes, S
Pasaoglu, I
Unal, S
Citation: Y. Cetinkaya et al., A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common, INT J ANT A, 18(1), 2001, pp. 1-7
Authors:
Lortholary, O
Ascioglu, S
Moreau, P
Herbrecht, R
Marinus, A
Casassus, P
De Pauw, B
Denning, DW
Citation: O. Lortholary et al., Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: A European organization for research and treatment of cancer, CLIN INF D, 30(1), 2000, pp. 41-46
Citation: S. Ascioglu et al., Prophylaxis and treatment of fungal infections associated with haematological malignancies, INT J ANT A, 15(3), 2000, pp. 159-168